AIM: It is not clear how the podocyte damage manifests in different glomerulopathies. This study evaluated the podocyte-associated mRNA profiles in renal tissue and urine of patients with proliferative (PGs) or non-proliferative (NPGs) glomerulopathies. METHODS: Messenger RNA levels of nephrin, podocin, podocalyxin, synaptopodin, and alpha-actinin-4 were measured in the kidney tissue and urinary cells by real-time polymerase chain reaction. Podocyte-associated mRNAs were correlated with proteinuria and renal function, and the effect of immunosuppressive treatment of PGs and NPGs on urine mRNAs was assessed up to one year of follow up. RESULTS: Podocyte-associated mRNAs were expressed consistently less in kidney tissue from patients with NPGs, and urinary podocyte mRNA levels were significantly higher in the PG group. After six months of immunosuppressive therapy, patients with PGs showed a significant reduction in the expression of podocin, podocalyxin, and alpha-actinin-4 compared with baseline (p<0.001). In the NPG group, alpha-actinin-4 levels decreased (p=0.008), and there was also a trend toward reduced podocalyxin mRNA (p=0.08). Urine podocyte-associated mRNAs correlated with the level of proteinuria at baseline and at six months, and there was a trend toward an inverse correlation between urinary mRNAs and kidney function at one year of follow up. CONCLUSIONS: Podocyte-associated mRNAs were inhibited in kidney tissue concomitantly with their increase in urine in these patients with glomerulopathies. Different profiles of mRNA expression were seen, pointing to a higher degree of intra-renal podocytopenia in the NPGs and of podocyturia in the PGs. The immunosuppressive therapy effectively reduced the urinary levels of podocyte-associated mRNAs.
AIM: It is not clear how the podocyte damage manifests in different glomerulopathies. This study evaluated the podocyte-associated mRNA profiles in renal tissue and urine of patients with proliferative (PGs) or non-proliferative (NPGs) glomerulopathies. METHODS: Messenger RNA levels of nephrin, podocin, podocalyxin, synaptopodin, and alpha-actinin-4 were measured in the kidney tissue and urinary cells by real-time polymerase chain reaction. Podocyte-associated mRNAs were correlated with proteinuria and renal function, and the effect of immunosuppressive treatment of PGs and NPGs on urine mRNAs was assessed up to one year of follow up. RESULTS: Podocyte-associated mRNAs were expressed consistently less in kidney tissue from patients with NPGs, and urinary podocyte mRNA levels were significantly higher in the PG group. After six months of immunosuppressive therapy, patients with PGs showed a significant reduction in the expression of podocin, podocalyxin, and alpha-actinin-4 compared with baseline (p<0.001). In the NPG group, alpha-actinin-4 levels decreased (p=0.008), and there was also a trend toward reduced podocalyxin mRNA (p=0.08). Urine podocyte-associated mRNAs correlated with the level of proteinuria at baseline and at six months, and there was a trend toward an inverse correlation between urinary mRNAs and kidney function at one year of follow up. CONCLUSIONS: Podocyte-associated mRNAs were inhibited in kidney tissue concomitantly with their increase in urine in these patients with glomerulopathies. Different profiles of mRNA expression were seen, pointing to a higher degree of intra-renal podocytopenia in the NPGs and of podocyturia in the PGs. The immunosuppressive therapy effectively reduced the urinary levels of podocyte-associated mRNAs.
Authors: T Nakamura; C Ushiyama; M Hara; S Osada; K Ugai; N Shimada; K Hayashi; I Ebihara; H Koide Journal: Clin Nephrol Date: 2002-02 Impact factor: 0.975
Authors: S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi Journal: Am J Pathol Date: 2001-05 Impact factor: 4.307
Authors: Darren J Kelly; Petri Aaltonen; Alison J Cox; Jon R Rumble; Robyn Langham; Sianna Panagiotopoulos; George Jerums; Harry Holthöfer; Richard E Gilbert Journal: Nephrol Dial Transplant Date: 2002-07 Impact factor: 5.992
Authors: Jonathan Fraportti do Nascimento; Luis H Canani; Fernando Gerchman; Patricia G Rodrigues; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco V Veronese Journal: BMC Nephrol Date: 2013-10-08 Impact factor: 2.388
Authors: Mariane dos Santos; Rafael N Bringhenti; Patrícia G Rodrigues; Jonathan F do Nascimento; Sane V Pereira; Rafael Zancan; Odirlei A Monticielo; Andrese A Gasparin; Waldir P de Castro; Francisco V Veronese Journal: Int J Clin Exp Pathol Date: 2015-05-01
Authors: Ony Araújo Galdino; Iago de Souza Gomes; Renato Ferreira de Almeida Júnior; Maria Imaculada Conceição Ferreira de Carvalho; Bento João Abreu; Marcela Abbott Galvão Ururahy; Barbara Cabral; Silvana Maria Zucolotto Langassner; Karla Simone Costa de Souza; Adriana Augusto de Rezende Journal: Sci Rep Date: 2022-10-20 Impact factor: 4.996